13 results
·
21ms
·
Sources: EU EUDAMED, US FDA
Filters
Regulation: Us FDA
×
PTA, PTV, ATRIOSEPTOSTOMY, ANGIOGRAPHIC, SIZING CATHETERS
FDA 510(k)
FDA Class 2
·Cardiovascular
N.A.
FDA UDI
Forestadent Bernhard Förster GmbH·EFOR20408301·Arch wires Titanol Superelastic Straight-Arch-F...
i-ED COIL
FDA UDI
KANEKA CORPORATION·04540778177659·The i-ED COIL is used for vascular embolization...
neoWave LS
FDA UDI
XENIX MEDICAL LLC·00818345023888·BAYONETTED PUSH SCRAPER CURETTE
CANNULATION TOURNIQUET SET, 2 TUBE OR 5 TUBE
FDA 510(k)
FDA Class 2
·Cardiovascular
POWDER FREE TEXTURED VINYL EXAMINATION GLOVES
FDA 510(k)
FDA Class 1
·General Hospital
COMPLETE
FDA Adverse Event
Injury
·JOHNSON & JOHNSON SURGICAL VISION, INC.·Product code LPN·April 17, 2020
FUSION TITAN DILATION BALLOON
FDA Adverse Event
Malfunction
·COOK INC·Product code FGE·May 4, 2018
ENDOTAK RELIANCE
FDA Adverse Event
Injury
·CPI - DEL CARIBE·Product code NVY·April 8, 2013
PENUMBRA SYSTEM
FDA Adverse Event
Death
·PENUMBRA, INC.·Product code NRY·March 31, 2011
TRAPEZOID RX LITHOTRIPTER COMPATIBLE BASKET
FDA Adverse Event
Malfunction
·BOSTON SCIENTIFIC CORPORATION·Product code LQC·May 9, 2008
PF-VIRTEC SYSTEM CMTED LAT.6
FDA Adverse Event
Injury
·ZIMMER SWITZERLAND MANUFACTURING GMBH·Product code LZO·August 6, 2019
Quadra Assura, Model No. CD3265-40, CD3265-40Q, CD3365-40C, CD3365-40Q. Quadra Assura MP, Model No. CD3269-40, CD3269-40Q, CD3369-40C. Fortify and Fortify Assura implantable cardioverter defibrillators (ICDS) are intended to provided ventricular anti-tachycardia pacing and ventricular defibrillation for automated treatment of life threatening ventricular arrhythmias. The devices may also be programmed to provide single or dual chamber bradycardia pacing. Unify and Unify Assura cardiac resynchronization therapy defibrillators (CRTDs) are intended to provide ventricular anti-tachycardia pacing and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias. The devices may also be programmed to provide single or dual chamber bradycardia pacing, in additional to cardiac resynchronization therapy via left ventricular pacing
FDA Enforcement
Class I
·Terminated·St Jude Medical Inc.·November 2, 2016